Meta-analysis finds invasive therapy reduces MI and revascularization in elderly NSTEMI patients
Older Heart Attack Patients Do Better With Stents But Face Bleeding Risks
This systematic review and meta-analysis of 2997 elderly patients with NSTEMI found that invasive therapies, compared with medical therapy, …
New data shows stents help older heart attack patients avoid repeat events but do not lower overall death rates compared to medicine alone.
ALBI score predicts mortality risk in patients with non-ST-segment elevation myocardial infarction
ALBI Score Predicts Heart Attack Survival Risk
This retrospective cohort study of 982 patients with non-ST-segment elevation myocardial infarction (NSTEMI) evaluated the albumin-bilirubin…
This simple liver test may help predict which heart attack patients face the highest risk after leaving the hospital.
Residual global μQFR assessment associated with 3-year MACE risk in acute coronary syndrome patients
Better Heart Maps Predict Long-Term Survival
This post hoc analysis of a randomized controlled trial evaluated 2,428 acute coronary syndrome patients over 36.0 months.
A new heart map predicts long-term survival just as well as expensive pressure wires, helping doctors spot high-risk patients after stent pr…
Research across Myocardial ischemia
Related studies from across the Myocardial ischemia family.
Impella CP improves survival in selected cardiogenic shock patients while routine early VA-ECMO lacks clear benefit
New data clarifies the role of heart pumps in shock
This narrative review examines the use of VA-ECMO and microaxial-pump strategies in patients with cardiogenic shock and ST-elevation myocard…
New research looks at how heart pumps and bypass machines help patients with severe heart damage after a heart attack.
Individualized mechanical circulatory support is necessary as increased hemodynamic support does not uniformly improve survival
Mechanical Support for Cardiogenic Shock Does Not Uniformly Improve Survival
This mini review examines the role of short-term mechanical circulatory support (MCS) in patients with cardiogenic shock, including those wi…
Newer reviews suggest that while mechanical support helps heart function, it does not always lead to better survival rates for patients in c…
Qili Qiangxin plus conventional medicine improves surrogate markers in heart failure after myocardial infarction
Qili Qiangxin May Improve Heart Function After Heart Attack
This meta-analysis of 1391 patients found that Qili Qiangxin combined with conventional Western medicine led to greater reductions in NT-pro…
Adding Qili Qiangxin to standard medicine may improve heart function and quality of life for patients following a heart attack.
OMI/NOMI approach increases immediate invasive management to 45.4% compared to 13.6% in myocardial infarction
New approach helps doctors find blocked heart arteries more quickly during emergencies
This multicenter randomized controlled trial substudy evaluated 4398 adult patients with myocardial infarction to compare the OMI/NOMI appro…
A new way of looking at heart attacks helps doctors find blocked arteries faster, leading to quicker treatment for patients in need.
NLRP3 inflammasome activation serves as a molecular bridge between myocardial infarction and depression
Inflammasome Activation Links Heart Attacks and Depression
This systematic review examines the role of the NLRP3 inflammasome in the link between myocardial infarction and depression. The authors con…
A specific inflammatory pathway called NLRP3 may act as a bridge between heart attacks and depression, potentially offering a new target for…
Beta-blocker therapy shows no significant reduction in primary composite outcomes for patients with LVEF ≥ 40%
Beta-blocker therapy shows mixed results for heart attack patients
This meta-analysis of 18,504 patients with acute myocardial infarction and LVEF ≥ 40% found no significant reduction in the primary composit…
New data suggests beta-blockers may only show a significant benefit for heart attack patients with specific levels of heart muscle function.
Beta-blocker outcomes vary by myocardial infarction type and left ventricular ejection fraction
Trial shows different heart medication effects based on heart attack type
This prespecified subgroup analysis examined the impact of beta-blockers on primary outcomes in patients with STEMI and NSTEMI. The findings…
New data suggests that beta-blockers may have different impacts on patients depending on the specific type of heart attack they experience.
Naoxintong Supplementation Reduces Heart Failure Risk Following Acute Myocardial Infarction
New treatment may lower heart failure risk after heart attack
A randomized trial suggests that adding Naoxintong to standard therapy significantly reduces heart failure incidence and MACE rates post-AMI…
A new study shows that adding a herbal formula to standard care can significantly reduce heart failure risk for patients after a heart attac…
Clinical signs, imaging, and biomarkers facilitate risk stratification for cardiac rupture in myocardial infarction
New tools help doctors predict life-threatening heart ruptures after heart attacks
This mini review synthesizes clinical warning signs, point-of-care imaging, and biomarker trajectories to stratify risk of cardiac rupture i…
Doctors are developing a new four-step plan to spot early warning signs of heart rupture, a condition where the heart muscle tears during a …
Intravenous nicorandil did not significantly reduce primary composite outcomes in patients with STEMI
Trial shows intravenous nicorandil does not improve heart attack outcomes
This randomized controlled trial of 1,503 patients with STEMI found no significant difference in the primary composite outcome between intra…
A large trial of over 1,500 patients found that the drug nicorandil did not improve primary outcomes for those with a heart attack.
DeepSeek AI generates guideline-conforming exercise prescriptions for myocardial infarction, heart failure, and atrial fibrillation
AI Shows Potential for Creating Heart Health Exercise Plans
This guideline-based simulation study evaluates the use of the DeepSeek model to generate exercise prescriptions for patients with myocardia…
A simulation study shows that AI can generate safe, guideline-based exercise plans for patients with heart conditions like heart failure and…
Functional Coronary Angiography Improves Clinical Outcomes in Multivessel STEMI Patients
Physiology guided heart procedures show lower risk of major events
Physiology-guided revascularization significantly reduces major adverse cardiac events and improves safety profiles compared to traditional …
A large international trial shows that using functional imaging to guide heart artery procedures may lower the risk of stroke and heart atta…
Questions about non-ST-segment elevation myocardial infarction
Can the ALBI score predict how long I might live after NSTEMI?
Yes, the ALBI score can predict mortality risk after NSTEMI, with higher scores indicating a significantly higher risk of death.
Full answer →